Immunomedics Competitors

Summary

Immunomedics competes with Microchip Technology, Micron Technology, Qorvo, Titan Machinery, and Teradyne; as well as few others. The company conducts business under Healthcare sector and is part of Biotechnology industry. Analyzing Immunomedics competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Immunomedics to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Immunomedics competition on your existing holdings.

Specify up to 10 symbols:

Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Immunomedics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.

Hype

Prediction

Low	Estimated	High
0.00	0.00	0.00

Details

Intrinsic

Valuation

Low	Real	High
0.00	0.00	0.00

Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Immunomedics. Your research has to be compared to or analyzed against Immunomedics' peers to derive any actionable benefits. When done correctly, Immunomedics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Immunomedics.

Immunomedics Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Immunomedics and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Immunomedics and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Immunomedics does not affect the price movement of the other competitor.

	MCHP	MU	QRVO	TITN	TER	TBBB
MCHP		0.48	0.28	-0.27	0.77	0.4	MCHP
MU	0.48		0.41	-0.86	0.59	0.61	MU
QRVO	0.28	0.41		-0.4	0.31	0.47	QRVO
TITN	-0.27	-0.86	-0.4		-0.41	-0.57	TITN
TER	0.77	0.59	0.31	-0.41		0.55	TER
TBBB	0.4	0.61	0.47	-0.57	0.55		TBBB
	MCHP	MU	QRVO	TITN	TER	TBBB

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

High positive correlations

TER	+ 0.77	MCHP
TBBB	+ 0.61	MU
TER	+ 0.59	MU
TBBB	+ 0.55	TER
MU	+ 0.48	MCHP
TBBB	+ 0.47	QRVO

High negative correlations

TITN	- 0.86	MU
TBBB	- 0.57	TITN
TER	- 0.41	TITN
TITN	- 0.4	QRVO
TITN	- 0.27	MCHP

Risk-Adjusted Indicators

There is a big difference between Immunomedics Stock performing well and Immunomedics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Immunomedics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
MCHP	1.58	(0.07)	(0.02)	0.01	2.03	(1.55)	3.40	(3.90)	11.12
MU	2.06	0.49	0.22	0.39	1.92	(2.31)	5.43	(3.35)	18.04
QRVO	1.62	0.03	0.04	0.06	1.90	(1.69)	3.61	(3.32)	11.79
TITN	1.82	(0.31)	0.00	(0.09)	0.00	0.00	3.92	(4.11)	12.27
TER	1.82	(0.13)	0.00	(0.01)	0.00	0.00	3.23	(3.89)	10.71
TBBB	2.24	0.29	0.11	0.52	2.35	(2.76)	4.11	(4.08)	14.99

Immunomedics Competitive Analysis

The better you understand Immunomedics competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Immunomedics' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Immunomedics' competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	MCHP	MU	QRVO	TITN	TER	TBBB
	1.00 85.07 Microchip	4.47 116.33 Micron	1.08 109.95 Qorvo	1.21 22.79 Titan	2.73 102.07 Teradyne	3.03 20.05 BBB
Market Volatility (90 Days Market Risk)	Very steady	Very steady	Very steady	Not too volatile	Very steady	Not too volatile
Market Performance (90 Days Performance)	Very Weak	Good	Insignificant	Very Weak	Very Weak	OK
Odds of Financial Distress (Probability Of Bankruptcy)	Low	Low	Low	Low	Low	High
Current Valuation (Equity Enterprise Value)	Under Valued	Over Valued	Fairly Valued	Over Valued	Fairly Valued	Fairly Valued
Buy or Sell Advice (Average Analysts Consensus)	Strong Buy	Strong Buy	Buy	Strong Buy	Buy	Buy
Trade Advice (90 Days Macroaxis Advice)	Hold	Buy	Strong Hold	Cautious Hold	Strong Hold	Strong Hold
Current Ratio	1.78 X	2.89 X	3.30 X	1.77 X	3.03 X	N/A
Net Asset	16.37 B	64.25 B	6.69 B	1.99 B	3.49 B	11.79 B
Profit Margin	0.28 %	(0.21) %	(0.06) %	0.04 %	0.17 %	N/A
EBITDA	3.78 B	2.66 B	193.09 M	201.42 M	611.77 M	N/A
Current Valuation	51.88 B	140.22 B	11.69 B	1.56 B	15.33 B	N/A
Price To Book	6.54 X	3.09 X	2.96 X	0.81 X	6.41 X	N/A
Operating Margin	0.30 %	0.03 %	0.13 %	0.05 %	0.19 %	N/A
Retained Earnings	5.76 B	40.82 B	84.5 M	397.23 M	706.51 M	(5.65 B)
Current Asset	3.1 B	9.49 B	1.51 B	858.25 M	809.27 M	N/A
Five Year Return	1.46 %	0.34 %	N/A	N/A	0.57 %	N/A
Beta	1.63	1.28	1.56	1.4	1.53	N/A
Number Of Employees	22.6 K	43 K	8.5 K	3.34 K	6.5 K	18.15 K
Shares Outstanding	540.39 M	1.11 B	96.55 M	22.85 M	152.97 M	N/A
Cash Flow From Operations	3.62 B	1.56 B	843.23 M	(400.39 M)	585.23 M	N/A
Annual Yield	0.02 %	0 %	N/A	N/A	0 %	N/A
Total Debt	6.44 B	13.93 B	2.05 B	1.08 B	82.61 M	491.24 M
Return On Equity	0.35	-0.0827	-0.0542	0.19	0.18	N/A
Return On Asset	0.12	-0.0377	0.0159	0.0664	0.0924	N/A
Number Of Shares Shorted	26.09 M	22.82 M	2.3 M	726.64 K	5.64 M	N/A
Book Value Per Share	13.10 X	39.63 X	37.63 X	29.21 X	16.54 X	N/A
Current Liabilities	382.01 M	4.83 B	373.8 M	523.42 M	279.37 M	N/A
Total Asset	16.37 B	64.25 B	6.69 B	1.99 B	3.49 B	11.79 B
Debt To Equity	1.27 %	0.15 %	0.48 %	0.91 %	0.06 %	N/A
Short Ratio	4.49 X	0.83 X	1.89 X	3.58 X	3.09 X	N/A
Target Price	93.12	135.89	116.36	31.8	115.75	N/A
Last Dividend Paid	1.59	0.46	N/A	N/A	0.44	N/A
Shares Owned By Institutions	95.65 %	84.96 %	90.22 %	81.65 %	99.56 %	N/A
Market Capitalization	46.44 B	134.84 B	10.73 B	532.15 M	16.05 B	N/A
Price To Earning	59.00 X	19.60 X	23.47 X	40.56 X	21.05 X	N/A
Price To Earnings To Growth	8.47 X	1.12 X	0.47 X	(2.80) X	1.34 X	N/A
Price To Sales	5.42 X	7.41 X	3.11 X	0.19 X	6.05 X	N/A
Net Income	2.24 B	(5.83 B)	103.15 M	110.92 M	448.75 M	N/A
Earnings Per Share	4.28 X	(3.43) X	(2.08) X	4.93 X	2.73 X	N/A
Shares Owned By Insiders	2.08 %	0.28 %	0.53 %	10.62 %	0.44 %	N/A
Revenue	8.44 B	15.54 B	3.57 B	2.76 B	2.68 B	N/A
Working Capital	(49.3 M)	16.48 B	1.47 B	371.1 M	1.5 B	(3.21 B)
Cash And Equivalents	379.1 M	9.33 B	858.79 M	142.06 M	776.06 M	N/A
Cash Per Share	0.69 X	8.58 X	8.32 X	6.38 X	4.96 X	N/A
Gross Profit	4.45 B	(1.42 B)	1.3 B	439.84 M	1.87 B	N/A
Day Typical Price	85.6	118.98	110.37	22.91	102.85	19.86
Accumulation Distribution	0.0268	0.0661	0.0198	0.0228	0.0323	19685.17
Market Facilitation Index	2.33	8.22	2.21	0.53	3.39	0.0
Daily Balance Of Power	(0.37)	(0.66)	(0.54)	(0.53)	(0.84)	0.9833
Period Momentum Indicator	(0.86)	(5.44)	(1.20)	(0.28)	(2.86)	0.59
Rate Of Daily Change	0.99	0.96	0.99	0.99	0.97	1.03
Day Median Price	85.87	120.31	110.58	22.98	103.24	19.76
Price Action Indicator	(1.23)	(6.70)	(1.23)	(0.33)	(2.60)	0.59
Relative Strength Index	44.38	57.79	46.85	40.91	43.75	N/A
Coefficient Of Variation	9004.98	525.15	1582.28	(1,266)	(19,833)	883.94
Mean Deviation	1.58	2.06	1.62	1.82	1.82	2.24
Jensen Alpha	(0.07)	0.4922	0.033	(0.31)	(0.13)	0.286
Total Risk Alpha	(0.13)	0.3428	(0.03)	(0.38)	(0.19)	0.1072
Sortino Ratio	(0.02)	0.2173	0.0367	N/A	N/A	0.1085
Downside Variance	4.28	5.56	4.14	N/A	N/A	6.11
Standard Deviation	2.05	2.98	2.06	2.44	2.32	2.86
Kurtosis	0.6403	5.47	0.7239	1.11	0.5372	0.6011
Potential Upside	3.4	5.43	3.61	3.92	3.23	4.11
Treynor Ratio	0.007	0.3856	0.0627	(0.09)	(0.01)	0.5183
Maximum Drawdown	11.12	18.04	11.79	12.27	10.71	14.99
Variance	4.19	8.9	4.24	5.97	5.38	8.18
Market Risk Adjusted Performance	0.017	0.3956	0.0727	(0.08)	5.0E-4	0.5283
Risk Adjusted Performance	0.0139	0.1279	0.0468	(0.04)	0.0041	0.0791
Skewness	0.1848	1.46	0.0171	(0.36)	(0.48)	0.3003
Semi Deviation	2.03	1.92	1.9	N/A	N/A	2.35
Information Ratio	(0.02)	0.1718	0.0363	(0.10)	(0.03)	0.0937
Value At Risk	(3.90)	(3.35)	(3.32)	(4.11)	(3.89)	(4.08)
Expected Short fall	(1.55)	(2.31)	(1.69)	N/A	N/A	(2.76)
Downside Deviation	2.07	2.36	2.03	N/A	N/A	2.47
Semi Variance	4.12	3.69	3.63	N/A	N/A	5.53

Immunomedics Competition Performance Charts

Five steps to successful analysis of Immunomedics Competition

Immunomedics' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Immunomedics in relation to its competition. Immunomedics' competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of Immunomedics in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Immunomedics' competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Immunomedics, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Immunomedics position

In addition to having Immunomedics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Soft Drinks Thematic Idea Now

Soft Drinks

Entities manufacturing and distributing non alcoholic beverages across different markets. The Soft Drinks theme has 44 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Soft Drinks Theme or any other thematic opportunities.

View All Next

Launch

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Consideration for investing in Immunomedics Stock

If you are still planning to invest in Immunomedics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Immunomedics' history and understand the potential risks before investing.

	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	AI Investment Finder Use AI to screen and filter profitable investment opportunities
	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC